Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice

Journal of Lipid Research

Volumn 49, Issue 4, 2008, Pages 790-796

  Dullens, Stefan P J ^a   Mensink, Ronald P ^a   Bragt, Marjolijn C E ^a   Kies, Arie K ^b   Plat, Jogchum ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DSM FOOD SPECIALTIES   (Netherlands)

Author keywords

CHD; High density lipoproteins; Low density lipoproteins; Nutrition

Indexed keywords

ABC TRANSPORTER A1; ALDEHYDE DERIVATIVE; APOLIPOPROTEIN A1; CHOLESTEROL; HEXACOSANOL; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE 1; LESSTANOL; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; OCTACOSANOL; POLICOSANOL; TETRACOSANOL; TRIACONTANOL; UNCLASSIFIED DRUG; FATTY ALCOHOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CELL STRAIN HEPG2; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORONARY RISK; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMALL INTESTINE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECT; EMULSION; GENE EXPRESSION REGULATION; GENETICS; HETEROZYGOTE; METABOLISM; MOUSE MUTANT; SOLUTION AND SOLUBILITY; TUMOR CELL LINE;

ANIMALS; APOLIPOPROTEIN A-I; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHOLESTEROL; EMULSIONS; FATTY ALCOHOLS; FEMALE; GENE EXPRESSION REGULATION; HETEROZYGOTE; HUMANS; INTESTINE, SMALL; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; SOLUTIONS;

EID: 44949087861     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700497-JLR200     Document Type: Article

References (27)

1. Marinangeli, C. P., A. N. Kassis, D. Jain, N. Ebine, S. C. Cunnane, and P. J. Jones. 2007. Comparison of composition and absorption of sugarcane policosanols. Br. J. Nutr. 97: 381-388.
2. Irmak, S., and N. T. Dunford. 2005. Policosanol contents and compositions of wheat varieties. J. Agric. Food Chem. 53: 5583-5586.
3. Hargrove, J. L., P. Greenspan, andD.K.Hartle. 2004.Nutritional significance and metabolism of very long chain fatty alcohols and acids from dietary waxes. Exp. Biol. Med. (Maywood). 229: 215-226.
4. Gouni-Berthold, I., and H. K. Berthold. 2002. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am. Heart J. 143: 356-365.
5. Lin, Y., M. Rudrum, R. P. van der Wielen, E. A. Trautwein, G. McNeill, A. Sierksma, and G. W. Meijer. 2004. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations. Metabolism. 53: 1309-1314.
6. Greyling, A., C. De Witt, W. Oosthuizen, and J. C. Jerling. 2006. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholes- terolaemic subjects. Br. J. Nutr. 95: 968-975.
7. Berthold, H. K., S. Unverdorben, R. Degenhardt, M. Bulitta, and I. Gouni-Berthold. 2006. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. J. Am. Med. Assoc. 295: 2262-2269.
8. Kassis, A. N., and P. J. Jones. 2006. Lack of cholesterol-lowering efficacy of Cuban sugar cane policosanols in hypercholesterolemic persons. Am. J. Clin. Nutr. 84: 1003-1008.
9. Dulin, M. F., L. F. Hatcher, H. C. Sasser, and T. A. Barringer. 2006. Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Am. J. Clin. Nutr. 84: 1543-1548.
10. Cubeddu, L. X., R. J. Cubeddu, T. Heimowitz, B. Restrepo, G. A. Lamas, and G. B. Weinberg. 2006. Comparative lipid- lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. Am. Heart J. 152: 982 e981-985.
11. Castano, G., L. Fernandez, R. Mas, J. Illnait, J. Fernandez, M. Mesa, E. Alvarez, and M. Lezcay. 2002. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hyper- cholesterolemia. Int. J. Clin. Pharmacol. Res. 22: 55-66.
12. Singh, H., N. Derwas, and A. Poulos. 1987. Very long chain fatty acid beta-oxidation by rat liver mitochondria and peroxisomes. Arch. Biochem. Biophys. 259: 382-390.
13. Noa, M., R. Mas, M. C. de la Rosa, and J. Magraner. 1995. Effect of policosanol on lipofundin-induced atherosclerotic lesions in rats. J. Pharm. Pharmacol. 47: 289-291.
14. Menendez, R., L. Arruzazabala, R. Mas, A. Del Rio, A. M. Amor, R. M. Gonzalez, D. Carbajal, V. Fraga, V. Molina, and J. Illnait. 1997. Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet. Br. J. Nutr. 77: 923-932.
15. Menendez, R., D. Marrero, R. Mas, I. Fernandez, L. Gonzalez, and R. M. Gonzalez. 2005. In vitro and in vivo study of octacosanol metabolism. Arch. Med. Res. 36: 113-119.
16. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus- mediated gene delivery. J. Clin. Invest. 92: 883-893.
17. Hartle, D. K., J. L. Hargrove, and P. Greenspan. 2005. Nutraceutical use of grain sorghum wax lowers serum cholesterol in humans. FASEB J. 19: A89.
18. Ghesquiere, S. A., M. J. Gijbels, M. Anthonsen, P. J. van Gorp, I. van der Made, B. Johansen, M. H. Hofker, and M. P. de Winther. 2005. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition. J. Lipid Res. 46: 201-210.
19. Plat, J., and R. P. Mensink. 2002. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur. J. Clin. Invest. 32: 242-250.
20. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25: 402-408.
21. Singh, D. K., L. Li, and T. D. Porter. 2006. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation ofAMP-kinase. J. Pharmacol. Exp. Ther. 318: 1020-1026.
22. Giller, T., U. Hennes, and H. J. Kempen. 1995. Regulation of human apolipoprotein A-I expression in Caco-2 and HepG2 cells by all-trans and 9-cis retinoic acids. J. Lipid Res. 36: 1021-1028.
23. Dullens, S. P. J., R. P. Mensink, and J. Plat. 2007. Differential effects of individual fatty acids on de novo apoA-I production in differentiated CaCo-2 cells. Atheroscler. Suppl. 8: 223.
24. Kassis, A. N., C. P. Marinangeli, D. Jain, N. Ebine, and P. J. Jones. 2007. Lack of effect of sugar cane policosanol on plasma cholesterol in golden Syrian hamsters. Atherosclerosis. 194: 153-158.
25. Jones, P. J., P. B. Pencharz, and M. T. Clandinin. 1985. Absorption of 13C-labeled stearic, oleic, and linoleic acids in humans: application to breath tests. J. Lab. Clin. Med. 105: 647-652.
26. Sallee, V. L., and J. M. Dietschy. 1973. Determinants of intestinal mucosal uptake of short- and medium-chain fatty acids and alcohols. J. Lipid Res. 14: 475-484.
27. Bernard, A., and H. Carlier. 1991. Absorption and intestinal catabolism of fatty acids in the rat: effect of chain length and unsaturation. Exp. Physiol. 76: 445-455.